T. Andrew Crockett
Overview
T. Andrew Crockett received an average of $3M in total compensation, including $528K in salary, at Carbylan Therapeutics from 2017 to 2023.
2023Carbylan TherapeuticsChief Executive Officer
2022Carbylan TherapeuticsChief Executive Officer
2021Carbylan TherapeuticsChief Executive Officer
2020Carbylan TherapeuticsChief Executive Officer
2019Carbylan TherapeuticsChief Executive Officer
2018Carbylan TherapeuticsChief Executive Officer
2017Carbylan TherapeuticsChief Executive Officer
Source: SEC filings on August 14, 2023, August 25, 2020, and August 23, 2019.
Related executives
We found six more executives who work or worked at Carbylan Therapeutics.
Benjamin Palleiko
Carbylan Therapeutics
Chief Financial Officer
Christopher Yea
Carbylan Therapeutics
Chief Development Officer
Edward Feener
Carbylan Therapeutics
Chief Scientific Officer
David Renzi
Carbylan Therapeutics
Chief Operating Officer
Premchandran Ramiya
Carbylan Therapeutics
Vice President, Pharmaceutical Development & Supply Chain
Marcee Maroney
Carbylan Therapeutics